ArticleAnnals of hematology2023

Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation.

Kimimori Kamijo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.